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1. Introduction 
It has been shown that beef heart quinol-cyto- 
chrome c reductase (complex III) incorporated into 
phospholipid vesicles can drive proton translocation 
[ 1,2] . In such vesicles, quinol-cytochrome c reductase 
activity is inhibited in the absence of uncoupling 
agents or v~momycin + K’ [l-3] , and it is generally 
assumed that inhibition is due to the presgnce of a 
membrane potential or an electrochemical gradient 
of protons developed between the internal and 
external osmotic spaces [4-61. To date, however, 
little ~fo~ation has been published showing that 
qu~ol~ytochrome c reductase can be influenced 
in reconstituted vesicles by ionic movements between 
the two osmotic spaces. In the present study we 
show that duroquinol-cytochrome c reductase activity 
can be brought into equilibrium with a K+ diffusion 
potenti~, and that the enzyme is inactivated as the 
potential becomes more negative inside the vesicles. 
In addition, we also show, using the cationic dye 
safranine, that vesicles containing complex III can 
drive the formation of a membrane potential. 
2. Methods 
Complex III was prepared from beef heart mito- 
chondria as in [8] . Phospholipid vesicles containing 
complex III were prepared from soybean phos- 
pholipids (Sigma) as in [ 1,2] using the cholate 
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dialysis procedure [9] . The phospholipids were 
extracted with acetone [9] prior to use. Vesicles were 
prepared in 50 mM Tris-S04, pH 7.5, containing 
various concentrations of KC1 or NaCl as indicated in 
the fi8ure legends. Safranine uptake and duroquinol- 
cytochrome c reductase activity [2] were routinely 
measured in 1 ml buffer containing 50 mM Tris-S04, 
pH 7.5,1 mM EDTA, and varying amounts of KCl or 
NaCl to maintain osmolarity with the vesicles. Reduc- 
tion of cytochrome c was measured at 550-540 nm 
and safranine uptake was measured at 530-578 nm 
1101. 
Membrane potentials were calculated from the 
initial concentrations of K’ inside, [K+]in , and out- 
side, F+lout, using the Nerst equation: 
Em 
K’lin 
= 59 1% Elont 
For these calculations, [K+]in was assumed to be the 
same as the buffer [K’] during preparation of the 
vesicles. The concentration ratio of safranine, [S+]in/ 
[S+lo!.lt, was calculated assuming that a decrease in 
absorbance at 530-578 nm is proportional to 
safranine uptake, [S’]in , and that 100% uptake was 
achieved with no external K’ present. 
3. Results 
Figure 1 shows a typical experiment using liposomes 
containing complex III. As reported [ 11,131, a 
valinomycin-induced K’ diffusion potential drives the 
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Fig.1. K+-driven uptake of safranine into phospholipid vesicles 
reconstituted with beef heart complex III. Vesicles were 
prepared in 50 mM Tris-SO,, pH 7.5, 150 mM KC1 and 
1 mM EDTA. The reaction media contained 50 mM Tris-SO,, 
pH 7.5,150 mM NaCl, 1 mM EDTA, 75 c(g phospholipid and 
18 PM safranine in total vol. 1 ml. Valinomycin and FCCP 
were 0.5 pg/ml and 1 I.~M respectively. 
uptake of safranine. Safranine uptake can be prevented 
or reversed by any reagent which collapses the K+ 
gradient (fig.1). That safranine probes an electrical 
event across the liposomal membrane isshown in 
fig.2. As expected, the absolute xternal [K*] needed 
to prevent safranine uptake is dependent upon the 
[K+] inside the vesicles (flg.2A). However, when 
safranine uptake is plotted against the K+ concentra- 
tion gradient (ilg.2B), all points fall on the same line, 
regardless of absolute internal [K’] . A plot of the log 
of the accumulation ratio of safranine, log [S+]in/ 
P’l out, against the membrane potential, gives a 
straight line with a slope of 1 (data not shown). It 
should be noted, however, that the absolute absor- 
bance changes obtained for a particular liposomal 
preparation are strongly dependent upon the ratio of 
safranine to phospholipid, and must be taken into 
consideration when comparing quantitative results 
obtained with different liposomal preparations. 
Optimal absorbance changes are obtained with a 
ratio of 0.25 E.tmol safranine/mg phospholipid. 
Figure 3A shows that duroquinol-cytochrome c 
reductase activity is controlled by a K’ diffusion 
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Fig.2. Effects of internal K* concentration on safranine 
uptake by complex III-phospholipid vesicles. Experimental 
conditions were as given in fig.1 with the exception that 
vesicles were made in the presence of either 50 mM or 
150 mM KCl. As the external KC1 concentration was raised, 
the external NaCl concentration was decreased proportionally 
to maintain osmolarity with the internal KCl. 
potential. Since the membrane potential is calculated 
from the K’ concentration gradient i  is expressed as 
a positive value. It is clear, however, that as the mem- 
brane potential becomes more negative, as measured 
by safranine uptake, the enzyme become inactivated 
(fig3A). Safranine uptake and enzyme inactivation 
appear to be in equilibrium with each other (fig.3B) 
and with the K+ diffusion gradient (fig3C). 
Duroquinol-cytochrome c reductase also drives 
the formation of a membrane potential in llposomes, 
as indicated by the uptake of safranine (fig.4). 
Safranine uptake can be prevented or abolished by 
FCCP or valinomycin + K’, conditions which also 
activate duroquinol-cytochrome c reductase [l-3] . 
The slight net increase in absorbance observed in the 
presence of FCCP or valinomycin is due to interference 
from reduced cytochrome c at these wavelengths. 
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Fig.3. Control of duroquinol-cytochrome c reductase in complex III-phosphotipid vesicles by K* diffusion potentials. Conditions 
were as in fig.2 with the exception that 60 NM duroquinol and 12 ,uM cytochrome c were present in the media during the 
measurements of enzyme activity. Duroqu~ol-cytochrome c reductase activity and safranine uptake were initiated by the 
addition of 0.5 ctg va~omyc~. The enzymatic rates shown in the figure are the initial rates obtained after addition of valinomycin. 
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Discussion 
The present study shows that: 
Duroquinol-cytochrome c reductase in recon- 
stituted phospholipid vesicles can be brought into 
equilibrium with a K+ diffusion potential, and 
becomes inactivated as the membrane potential 
becomes more negative inside the vesicle. 
Duroqu~ol~ytochrome c reductase can drive the 
formation of a membrane potential in complex III 
vesicles, as shown by the uptake of safranine. 
The diffusion potential-driven uptake of safranine 
by complex III vesicles follows the Nernst equation 
Fig.4. Formation of a membrane potential driven by 
duroquinoi~ytochrome c reductase incorporated into phos- 
pholipid vesicles. The conditions of the assay were as in f&l 
and fig.3. 
and is a reliable qualitative proble of transmem- 
brane potentials. 
Complex III vesicles do not catalyze the reduction 
of cytochrome c unless an uncoup~ng agent or vali- 
nomycin + K* is present fI-31 . This has been inter- 
preted to mean that the first turnovers of the enzyme 
create a redoxdriven electrochemical proton gradient 
which is sufficient o inhibit electron-transfer [l-3] . 
The present observation that duroqu~ol~ytoc~ome 
c reductase isable to drive the uptake of safranine 
shows that the enzyme can form a membrane poten- 
tial, and is in keeping with the above interpretation. 
The present findings also clearly show that both 
sifranine uptake and duroquinol-cytochrome c 
reductase activity can be brought into eq~ibrium 
with a K’ diffusion gradient (fig.3), indicating that 
the enzyme can be controlled by ionic movements 
between the internal and external osmotic spaces. 
The effect of the ApH (pH gradient) on duroquinol- 
cytochrome c reductase activity has not yet been 
successfully determined ue: 
(i) To the lack of reliable methods for measuring 
internal pH in liposomal systems where the proton 
movement is directed outwards. 
(ii) To the fact that isolated duroquinol-cytochrome 
creductase is strongly pH dependent [3 ] , making 
acid-base transition experiments [ 131 difficult to 
interpret. 
It should be mentioned, however, that in several 
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experiments we have observed valinomycin-activated 
rates to be 20-40% lower than FCCP-activated rates. 
This difference in enzyme activity can be due to the 
influence of the ApH which is enhanced in the vali- 
nomycin-treated vesicles. 
We have attempted to use the K+-driven uptake of 
safranine as a standard to quantitate [ 1 l-l 31 mem- 
brane potentials formed under conditions of electron 
transport inhibition [l-3] . The results how that the 
duroquinol-cytochrome c reductase ishalf-maximally 
activated by a K’ diffusion potential of 90-95 mV. 
In contrast, duroquinol-cytochrome c reductase 
drives the formation of a potential no greater than 
10 mV, as measured by safranine (data not shown), 
even under conditions where electron transport is 
controlled [l-3] . This discrepancy ismost easily 
explained if, like cytochrome oxidase [14,151, 
complex III is incorporated into only a small percent 
of the vesicles. In this case, all vesicles would accumu- 
late safranine in the presence of a K* diffusion 
potential, whereas only a small percentage would 
accumulate safranine when driven by duroquinol- 
cytochrome c reductase. Quantitation of the 
membrane potential based upon K+-driven safranine 
uptake [12,13] would, thus, lead to a considerable 
underestimation f the enzyme-driven membrane 
potential. 
It would thus appear that the membrane potentials 
calculated from K’ diffusion gradients are probably 
nearest to those which actually control duroquinol- 
cytochrome c reductase activity (fig.3). Even these 
values are open to question, however, since they are 
based on the assumption that the K+-driven safranine 
response isindependent of the size of the liposomal 
vesicle. The size of the vesicle prepared by cholate 
dialysis can vary considerably [ 141. It now appears 
that proteins can be inserted into vesicles of a 
restricted and uniform size [ 141. Quantitation of 
membrane potentials in liposomal vesicles using 
safranine as a probe is, thus, associated with problems 
apparently not experienced with intact rat liver mito- 
chondria [12,13]. 
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